Results 131 to 140 of about 34,473 (219)

Therapeutic drug monitoring of voriconazole

, 2015
Invasive fungal diseases are associated with significant morbidity and mortality, especially in immunocompromised patients. Voriconazole is a first-line treatment for invasive aspergillosis, and an effective agent for candidiasis, fusariosis and ...
VIALE, PIERLUIGI, LEWIS, RUSSEL EDWARD
core   +1 more source

Clinical experience treating Paecilomyces lilacinus keratitis in four patients

Clinical Ophthalmology, 2012
Yu Monden,1 Minoru Sugita,1 Ryoji Yamakawa,1 Kazuko Nishimura,21Department of Ophthalmology, Kurume University School of Medicine, Kurume, Fukuoka, Japan; 2Medical Mycology Research Center, Chiba University and First Laboratories Co Ltd, Kawasaki ...
Monden Y, Sugita M, Yamakawa R, Nishimura K   +3 more
doaj  

Voriconazole

Drugs in R & D, 1999
openaire   +2 more sources

Voriconazole-Induced Pancreatitis Despite Therapeutic Trough Concentrations During Treatment of Disseminated Fusariosis in a Hospitalized Patient. [PDF]

Am J Case Rep
Aristilde B, Berguido de la Guardia ME, Fentie KF, Evans M, Rueda Prada L.   +4 more
europepmc   +1 more source

The Brief Case: Recalcitrant cutaneous and subcutaneous knee infection caused by <i>Purpureocillium lilacinum</i>. [PDF]

J Clin Microbiol
Li M-C, Wong T-W, Shih H, Hsieh M, Wu W-L, Pan S-C, Wu C-J.   +6 more
europepmc   +1 more source

Performance of the Sensititre YeastOne assay compared with EUCAST E.Def 9.4 against <i>Fusarium</i> clinical isolates: focus on voriconazole and amphotericin B. [PDF]

JAC Antimicrob Resist
Chen PY, Wu UI, Liu WD, Huang YT, Chen YC.   +4 more
europepmc   +1 more source

Voriconazole and Dexamethasone Drug Interaction in a Premature Neonate. [PDF]

J Pediatr Pharmacol Ther
Liviskie CJ, Lockowitz CR, McPherson CC, Riley MM, Hunstad DA.   +4 more
europepmc   +1 more source

Case Report: Dual toxicity of voriconazole in a CYP2C19 poor metabolizer: a case analysis of life-threatening neutropenia and hepatocellular injury. [PDF]

Front Pharmacol
Liu KK, Gong WJ.
europepmc   +1 more source

VALID regimen of voriconazole optimizes therapeutic target attainment and minimizes adverse events in patients with liver dysfunction. [PDF]

Front Pharmacol
Li J, Zhao Y, Liu H, Zhang Y, Ma J, Jiang Y, Zhao J, Zhang B, Yan M.   +8 more
europepmc   +1 more source

Repeated voriconazole therapeutic drug monitoring in hospitalised patients: a real-world cohort study of out-of-range exposure and concentration response to dose adjustment. [PDF]

Front Pharmacol
He T, Liu Z, Liang L, Qiao W, Chen S, Liu J, Liu M, Li W.   +7 more
europepmc   +1 more source